Literature DB >> 11123090

Cytokines and adhesion molecules in the pathogenesis of vasculitis.

J S Sundy1, B F Haynes.   

Abstract

Upregulated adhesion molecule and cytokine expression on endothelial cells and infiltrating inflammatory cells occur in most vasculitis syndromes. These observations suggest that vasculitis is associated with pathologic activation of normal immune cell cytokine cascades. Abnormal expression of adhesion molecules and cytokines in vascular endothelium is a manifestation of endothelial dysfunction that can be triggered by a variety of stimuli, including infectious agents, immune complexes, and antiendothelial cell antibodies. Dysregulated adhesion molecule expression, uncontrolled inflammation, thrombosis, and vessel occlusion lead to the clinical manifestations of vasculitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123090     DOI: 10.1007/s11926-000-0040-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

1.  Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.

Authors:  M Terai; T Jibiki; A Harada; Y Terashima; K Yasukawa; S Tateno; H Hamada; S Oana; H Niimi; K Matsushima
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

2.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Interferon-alpha treatment of four patients with the Churg-Strauss syndrome.

Authors:  E Tatsis; A Schnabel; W L Gross
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

4.  Vascular endothelial growth factor in acute Kawasaki disease.

Authors:  M Terai; K Yasukawa; S Narumoto; S Tateno; S Oana; Y Kohno
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

5.  Disease patterns and tissue cytokine profiles in giant cell arteritis.

Authors:  C M Weyand; N Tetzlaff; J Björnsson; A Brack; B Younge; J J Goronzy
Journal:  Arthritis Rheum       Date:  1997-01

6.  Impaired endothelium-mediated vasodilatation in the peripheral vasculature of patients with acute pulmonary allograft rejection.

Authors:  H Scherstén; K Kirnö; R Ekroth; S Lundin; A Pettersson; C Kjellström; V M Miller; F Nilsson
Journal:  J Heart Lung Transplant       Date:  1996-06       Impact factor: 10.247

Review 7.  The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy.

Authors:  T J DeGraba
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

8.  Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism.

Authors:  G Luvarà; M E Pueyo; M Philippe; C Mandet; F Savoie; D Henrion; J B Michel
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

9.  Increased serum levels of vascular endothelial growth factor in Kawasaki disease.

Authors:  N Maeno; S Takei; K Masuda; H Akaike; K Matsuo; I Kitajima; I Maruyama; K Miyata
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

10.  Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis.

Authors:  N P Burrows; F A Molina; G Terenghi; P K Clark; D O Haskard; J M Polak; R R Jones
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

View more
  8 in total

Review 1.  Cutaneous vasculitis.

Authors:  Samina Hayat; Seth Mark Berney
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 2.  Immunopathogenesis of vasculitis.

Authors:  Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 3.  Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.

Authors:  Theo Dov Golan
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

4.  Role of interleukin-6 in immune complex induced models of vascular injury.

Authors:  Shannon D McClintock; Adam G Barron; Eric W Olle; Michael P Deogracias; Roscoe L Warner; Mark Opp; Kent J Johnson
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

5.  Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.

Authors:  Tsuyoshi Kasama; Kumiko Ohtsuka; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Kazuo Kobayashi
Journal:  Arthritis       Date:  2010-12-26

Review 6.  The effects of anthrax lethal toxin on host barrier function.

Authors:  Tao Xie; Roger D Auth; David M Frucht
Journal:  Toxins (Basel)       Date:  2011-06-14       Impact factor: 4.546

7.  Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease.

Authors:  Tamar Aprahamian; Ian Rifkin; Ramon Bonegio; Bénédicte Hugel; Jean-Marie Freyssinet; Kaori Sato; John J Castellot; Kenneth Walsh
Journal:  J Exp Med       Date:  2004-04-19       Impact factor: 14.307

8.  Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.

Authors:  Hirohito Kanemitsu; Mizuho Matsunawa; Kuninobu Wakabayashi; Michihito Sato; Ryo Takahashi; Tsuyoshi Odai; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama
Journal:  Open Access Rheumatol       Date:  2009-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.